Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Maruho Hatsujyo Innovations Names COO | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Maruho Hatsujyo Innovations Names COO

Dr. Saarinen will be responsible for directing and overseeing operations, developing sales personnel and channels

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Timothy Saarinen has been appointed chief operating officer of Maruho Hatsujyo Innovations (MHI) Medical Packaging Machinery business. Dr. Saarinen will be responsible for directing and overseeing operations, developing sales personnel and channels, and strengthening products, services, and technical resources. MHI is the U.S. subsidiary of Maruho Co. Ltd, a Japanese dermatology pharmaceutical company with subsidiaries in Europe and the U.S.   
 


 
Dr. Saarinen joins the company from Amcor, a packaging provider, where he first served as commercial director, North America and then general manager, Mundelein. Prior to that, he was vice president of sales for Isotec. 
 
Dr. Saarinen will focus on providing customer guidance and consultation for – and continuing to raise market awareness of – Eagle, the company’s debut U.S. blister machine, as well as compact, high performance blister machines planned for 2018, including the Spirit (lab scale), Patriot (small production), and Denali (large scale production).

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters